Platten M - Search Results

1

Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10.

Hertenstein A, Schumacher T, Litzenburger U, Opitz CA, Falk CS, Serafini T, Wick W, Platten M. Hertenstein A, et al. Among authors: platten m. Biochem Pharmacol. 2011 Sep 15;82(6):632-41. doi: 10.1016/j.bcp.2011.06.013. Epub 2011 Jun 14. Biochem Pharmacol. 2011. PMID: 21703247

2

Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression.

Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M. Platten M, et al. Biochem Biophys Res Commun. 2000 Feb 16;268(2):607-11. doi: 10.1006/bbrc.2000.2176. Biochem Biophys Res Commun. 2000. PMID: 10679251

3

Role of TGF-beta in oncogenesis.

Weller M, Wick W, Platten M. Weller M, et al. Among authors: platten m. Microsc Res Tech. 2001 Feb 15;52(4):353. doi: 10.1002/1097-0029(20010215)52:4<353::AID-JEMT1019>3.0.CO;2-U. Microsc Res Tech. 2001. PMID: 11170293 No abstract available.

4

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

5

Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M. Wick W, et al. Among authors: platten m. J Neurosci. 2001 May 15;21(10):3360-8. doi: 10.1523/JNEUROSCI.21-10-03360.2001. J Neurosci. 2001. PMID: 11331365 Free PMC article.

6

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.

Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J, Weller M. Platten M, et al. Int J Cancer. 2001 Jul 1;93(1):53-61. doi: 10.1002/ijc.1289. Int J Cancer. 2001. PMID: 11391621

7

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma).

Platten M, Wick W, Wischhusen J, Weller M. Platten M, et al. Br J Pharmacol. 2001 Nov;134(6):1279-84. doi: 10.1038/sj.bjp.0704373. Br J Pharmacol. 2001. PMID: 11704648 Free PMC article.

8

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Wick W, Platten M, Weller M. Wick W, et al. Among authors: platten m. J Neurooncol. 2001 Jun;53(2):177-85. doi: 10.1023/a:1012209518843. J Neurooncol. 2001. PMID: 11716069 Review.

9

Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast).

Platten M, Eitel K, Wischhusen J, Dichgans J, Weller M. Platten M, et al. Biochem Pharmacol. 2003 Oct 1;66(7):1263-70. doi: 10.1016/s0006-2952(03)00449-0. Biochem Pharmacol. 2003. PMID: 14505805

10

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. Uhl M, et al. Among authors: platten m. Cancer Res. 2004 Nov 1;64(21):7954-61. doi: 10.1158/0008-5472.CAN-04-1013. Cancer Res. 2004. PMID: 15520202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters